Mueller T C, Nowak P, Johansson L. "Method for the Synthesis of Pazopanib Impurity 14" [P]. European Patent, EP 3420267 A1, 2015-05-04.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 帕唑帕尼杂质14 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2020, 1505, (12), 2761-2771.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 帕唑帕尼杂质14 as an Impurity". Anal. Methods, 2011, 1811, 4208-4233.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Pazopanib Impurity 14 Using HRMS and NMR". Environ. Sci. Technol., 2017, 1832, 1393-1405.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 帕唑帕尼杂质14 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2016, 713, (4), 8089-8097.